| 马平均.依达拉奉治疗急性脑梗死的疗效观察[J].实用中西医结合临床,2008,(3):4-5 |
| 依达拉奉治疗急性脑梗死的疗效观察 |
|
| |
| DOI： |
| 中文关键词: 依达拉奉 脑梗死 自由基清除剂 |
| 英文关键词: Edaravone cerebral infarction free radical scavenger |
| 基金项目: |
|
| 摘要点击次数: 608 |
| 全文下载次数: 293 |
| 中文摘要: |
| 目的：观察依达拉奉治疗急性脑梗死的临床效果。方法：选择急性脑梗死患者62例，随机分为依达拉奉治疗组和对照组。两组在常规治疗基础上，治疗组静脉滴注依达拉奉30mg/次，2次/d，共14d，治疗前后定期对患者进行改良爱丁堡一斯堪的那维亚量表(SSS)及日常生活能力(ADL)的评定。结果：治疗14d后治疗组SSS评分及ADL评定与对照组比较差异有显著性(P <0.05或0.01)。治疗组无不良反应。结论：依达拉奉治疗急性脑梗死是有效安全的。 |
| 英文摘要: |
| Objective:To observe the clinical efficacy of Edaravone in treatment of acute cerebral infarction.Methods:62 patients with acute cerebral infarction enrolled in this study were randomly allocated to Edaravone group and control group.Besides receiving traditional therapy，the Edaravone group received Edaravone 30 mg,twice a day for 14 days.The therapy of the control group was similar to those of Edaravone group except for Edaravone.The patients’condition was evaluated by using Scandinavian Stroke Scale(SSS)and activities of daily living(ADL)before treatment and on 14 days after treatment.Results:14 days after treatment，by comparison with the control group，an improved SSS and ADL had been obtained in the Edaravone group，there were statistically significant differences(P<0.05 or 0.01).No side effect in the Edaravone group.Conclusion:Edaravone is effective and safe in treatment of acute carebral infarction. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
